An interventional study of Arthroplasty and Internal Fixation in Femoral Neck Fractures, sponsored by University of Maryland, Baltimore. Active, not recruiting at 12 sites in 3 countries. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-02-13.
Sponsored by University of Maryland, Baltimore · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Femoral Neck Fractures with a site in United States — 7 open to participants now, 10 under way, none of them phase 3. Femoral Neck Fractures · United States.
Among the 26 studies in Femoral Neck Fractures with a site in United States, this one is the 17th largest by planned enrollment of the 23 interventional ones that give a count, is one of 5 that started in 2023, is one of 17 with no phase, and was the 22nd registered.
207 studies on the registry are indexed under Femoral Neck Fractures; 40 are open to participants now.
Browse Femoral Neck Fractures studies →7 of the 26 studies in Femoral Neck Fractures with a site in United States are open now. Recruiting first, the newest first:
University of Southern California · Sites in United States, Canada, Norway and 2 more countries
Ages 60+
University of Pennsylvania · Sites in United States
Ages 50+
University of Kansas Medical Center · Sites in United States
Ages 18+
Stanford University · Sites in United States
Ages 65+
Zimmer Biomet · Sites in United States
Ages 18–80
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 23 Femoral Neck Fractures studies recruiting now, 16 (70%) set no upper age limit and 4 (17%) stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.
This study: 60 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 5 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 100 across 142 interventional studies indexed under Femoral Neck Fractures.
Median enrollment 122 across the 23 interventional studies, 100 across the 3 observational. Of the 15 that completed or were terminated, 11 (73%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 26 have an industry lead sponsor. The 10 most frequent:
University of Maryland, Baltimore is the lead sponsor of 700 studies on the registry; 131 are open to participants now.
Of its 92 completed or terminated interventional studies of FDA-regulated products, 66 (72%) have results posted.
University of Maryland, Baltimore has 1 study filed under Femoral Neck Fractures — fewer than ten, so there is no comparison to draw.
2 of the studies in Femoral Neck Fractures with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05947058University of Maryland, BaltimoreMinimally Displaced Femoral Neck Fracture Pilot Study | 2026-12 |
| NCT06438640University of PennsylvaniaEvaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture) | 2027-06-15 |
Add all 2 to your calendar (.ics) → With an account.
Among the 26 studies in Femoral Neck Fractures with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this randomized pilot study is to assess feasibility of the trial and to collect information to inform the design of a definitive trial. Adult patients ages 60 years or older with a low-energy minimally displaced femoral neck fracture (FNF) treated with surgery will be eligible to participate in the study. Patients will be randomized to one of two treatment groups, hip arthroplasty or internal fixation. Participants will be followed for 1 year.
Nearly half of all elderly hip fractures are femoral neck fractures (FNFs) and approximately 20% are minimally displaced. Internal fixation has remained the treatment of choice for these injuries because these fractures can be fixed in situ and the surgical implants can be inserted with little surgical dissection. Patients treated with internal fixation experience high complication rates, with the pooled risk of reoperation and mortality each above 14%. Preliminary data have suggested arthroplasty for minimally displaced fractures may lead to better patient outcomes, including improved ambulation, fewer reoperations, and a lower risk of death compared to internal fixation. While the preliminary data supporting the use of arthroplasty for minimally displaced fractures is promising, the necessary evidence to make this significant practice change remains lacking.
The eventual definitive trial has significant potential to change clinical practice and optimize patient outcomes for individuals that experience a minimally displaced FNF. Treating minimally displaced FNFs with arthroplasty, instead of internal fixation, would be a paradigm shift in clinical care. This pilot study will demonstrate feasibility of the definitive trial and be used to refine aspects of the study protocol as necessary. If feasibility is successfully demonstrated, the pilot activities will be considered a vanguard phase for the definitive clinical trial.
Adult patients ages 60 years or older with a low-energy minimally displaced femoral neck fracture treated with surgery will be eligible to participate in the study. Patients will be randomized to receive either hip arthroplasty or internal fixation. Patients will be followed for 1 year, with visits occurring at 6 weeks, 4 months, 8 months, and 1 year after fracture. At each follow-up, mortality, ambulation, days at home, and health status will be collected.
The primary objective is to assess feasibility of the trial and to collect information to inform the design of the definitive trial. The feasibility outcomes will include participant enrollment, adherence to treatment allocation, data collection methods, and compliance with key aspects of the protocol.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A modern porous-coated press-fit or cemented hip arthroplasty prosthesis will be used at the treating surgeon's discretion. Press-fit implants that have no ingrowth or ongrowth surface will not be permitted. We recommend surgeons consider a total hip arthroplasty for younger active, independent participants; conversely, a hemiarthroplasty is recommended for more frail, lower-demand participants. Similarly, cemented arthroplasty for older adult participants is also recommended. The surgical approach and the use of post-operative hip precautions will be determined by the treating surgeon.
Procedure: Arthroplasty
Based on the fracture displacement eligibility criteria, minimal or no reduction is expected during the surgical procedure. However, the treating surgeon will be allowed to perform fracture reduction maneuvers if desired. Fixed angle devices and multiple screws will be permitted. The internal fixation device(s) will be inserted through a small lateral incision. If using multiple cancellous screws, an inverted triangle or similar screw pattern is recommended. Fixed angle devices, such as a sliding hip screw (with or without an anti-rotation screw) or newer multi-screw fixed angle devices will also be permitted. Internal fixation constructs combining cancellous screws and fixed angle devices will be permitted.
Procedure: Internal Fixation
The type of hip prothesis (hemi or total; cemented or uncemented) will be at the discretion of the treating surgeon.
Both fixed angle devices and multiple screws will be permitted for the internal fixation group.
Feasibility of Participant Enrollment
Participant enrollment will be assessed by monitoring screening and enrollment metrics, including: * Proportion of clinical sites initiated and able to screen consecutive patients with minimally displaced FNF * Proportion of patients who are screened for eligibility to participate in the trial * Proportion of patients who meet the eligibility criteria * Proportion of patients who provide informed consent * Proportion of time required to enroll at least four participants per clinical site * Proportion of reasons for exclusion.
Time frame: 12 months
Feasibility of Treatment Allocation
Feasibility of the treatment allocation will be assessed using the following metrics: * Adherence to arthroplasty treatment allocation * Adherence to internal fixation treatment allocation
Time frame: 12 months
Refine Data Collection Methods
To refine the data collection methods, the following metrics will be reviewed: * Proportion of participants with missing data * Review of missing data to identify data fields that are not feasible to collect * Data errors to identify ways to improve the flow of the case report forms (CRFs) and data collection
Time frame: 12 months
Assess Protocol Compliance
The following metrics will be used to assess compliance with the protocol: * Proportion of randomization errors * Proportion of participants who complete each follow-up visit * Proportion of participants who withdraw from the trial (withdrawal of consent) * Proportion of participants who cannot be located (loss to follow-up)
Time frame: 12 months
Started Nov 2023 (actual). Primary completion is estimated for Dec 2026, 37 months after the start.
Of 63 non-industry interventional studies with no phase under Femoral Neck Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 62. This study's planned 37 months is below that.
Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 25 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Maryland, Baltimore →